What is the evidence base?
The international context

Chlamydia trachomatis is a bacterial sexually transmitted infection (STI) of global public health significance. An estimated 89 million new cases of genital chlamydia infection occur each year, and untreated infection can lead to health consequences including pelvic inflammatory disease and ectopic pregnancy.

There are a wide variety of approaches used to manage chlamydia around the world, ranging from ad hoc approaches to nationally implemented programmes.

Chlamydia screening in the United Kingdom.

To view information on chlamydia screening in the United Kingdom click here.

Chlamydia screening in other countries.

To view information on chlamydia screening in other countries click here.

References

i - ECDC GUIDANCE Chlamydia control in Europe Stockholm, June 2009
ii - Jane S Hocking, Jennifer Walker, David Regan, Marcus Y Chen and Christopher K Fairley Chlamydia screening — Australia should strive to achieve what others have not MJA 2008; 188 (2): 106-108
iii - Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006;31:52-61


Be proactive
The National Chlamydia Screening Programme (NCSP) is a control and prevention programme targeted at the highest risk group for chlamydia infection in England, young people under 25 who are sexually active.

Chlamydia is often asymptomatic so a large proportion of cases remain undiagnosed, but infection can be diagnosed easily (young people can do the test themselves), and treated effectively.

To find your local Chlamydia Screening Office or to register with us enter your post code or select your region on the map

uk map North West North East Yorkshire and Humber East Midlands West Midlands East of England South West South Central London South East
Please enter full postcode: